Dennis Mangan and Dr. Mikhail Blagosklonny discuss how Dr. Blagosklonny’s cancer research led him to the study of aging, whether rapamycin is the most important anti-aging intervention currently available, his skepticism about metformin as an anti-aging drug, and more.
Aging (Aging-US) Authors
Dennis Mangan from MTOR LLC in Bakersfield, California details his theory article published by Aging (Aging-US), entitled, “Iron: an underrated factor in aging.”
PRESS RELEASE: Dr. Mikhail Blagosklonny published a new review paper in Aging (Aging-US), entitled, “Hallmarks of cancer and hallmarks of aging.”
PRESS RELEASE: Mikhail Blagosklonny, M.D., Ph.D., published a new research perspective about upcoming research at Altos Labs.
Following the Second Interventions in Aging Conference, meeting organizers Dr. Brian Kennedy and Dr. Linda Partridge discuss their overview of the meeting proceeding.
Dr. Michael Lisanti describes his 2020 paper published by Aging, entitled, “COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection?”
Dr. Marina Antoch from Roswell Park Comprehensive Cancer Center discusses her 2017 study published by Aging, entitled: “Physiological frailty index (PFI): quantitative in-life estimate of individual biological age in mice.”
Dr. Alex Zhavoronkov discusses his 2020 research paper published by Aging, entitled, “Geroprotective and senoremediative strategies to reduce the comorbidity, infection rates, severity, and lethality in gerophilic and gerolavic infections.”